Index
Measure ID |
Title |
eMeasure ID |
Measure Type |
NQF ID |
High Priority |
Submission Methods |
Risk Adjusted? |
Registry Measure? |
AAAAI11
|
Asthma Assessment and Classification
|
|
Process |
|
|
|
|
|
AAAAI12
|
Lung Function/Spirometry Evaluation
|
|
Process |
|
|
|
|
|
AAAAI17
|
Asthma Control: Minimal Important Difference Improvement
|
|
Outcome |
|
|
|
|
|
AAAAI18
|
Penicillin Allergy: Appropriate Removal or Confirmation
|
|
Outcome |
|
|
|
|
|
AAAAI19
|
Asthma: Pharmacologic Therapy for Persistent Asthma – Ambulatory Care Setting
|
|
Process |
|
|
|
|
|
AAAAI2
|
Asthma: Assessment of Asthma Control – Ambulatory Care Setting
|
|
Process |
|
|
|
|
|
AAAAI5
|
Allergen Immunotherapy Treatment: Allergen Specific Immunoglobulin E (IgE) Sensitivity Assessed and Documented Prior to Treatment
|
|
Process |
|
|
|
|
|
AAAAI6
|
Documentation of Clinical Response to Allergen Immunotherapy within One Year
|
|
Process |
|
|
|
|
|
AAAAI8
|
Achievement of Projected Effective Dose of Standardized Allergens for Patient Treated With Allergen Immunotherapy for at Least One Year
|
|
Outcome |
|
|
|
|
|
AAAAI9
|
Assessment of Asthma Symptoms Prior to Administration of Allergen Immunotherapy Injection(s)
|
|
Process |
|
|
|
|
|
AAD1
|
Psoriasis: Assessment of Psoriasis Disease Activity
|
|
Process |
|
|
|
|
|
AAD2
|
Psoriasis: Screening for Psoriatic Arthritis
|
|
Process |
|
|
|
|
|
Page 1 of 75